INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 179 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $496,000 | -21.3% | 10,353 | +3.5% | 0.01% | -44.0% |
| Q1 2020 | $630,000 | -49.2% | 10,000 | 0.0% | 0.02% | +25.0% |
| Q4 2019 | $1,239,000 | +33.4% | 10,000 | -28.6% | 0.02% | +5.3% |
| Q3 2019 | $929,000 | -10.2% | 14,000 | +7.7% | 0.02% | -29.6% |
| Q2 2019 | $1,034,000 | -28.9% | 13,000 | 0.0% | 0.03% | -25.0% |
| Q1 2019 | $1,454,000 | +570.0% | 13,000 | +550.0% | 0.04% | +227.3% |
| Q4 2016 | $217,000 | -34.0% | 2,000 | 0.0% | 0.01% | -45.0% |
| Q3 2016 | $329,000 | +26.5% | 2,000 | +9.7% | 0.02% | 0.0% |
| Q2 2016 | $260,000 | -74.7% | 1,823 | -77.2% | 0.02% | -55.6% |
| Q1 2016 | $1,028,000 | -23.5% | 8,000 | -11.1% | 0.04% | -51.6% |
| Q4 2015 | $1,344,000 | -37.7% | 9,000 | -30.8% | 0.09% | -2.1% |
| Q3 2015 | $2,156,000 | -55.3% | 13,000 | -35.0% | 0.10% | -50.3% |
| Q2 2015 | $4,828,000 | -31.5% | 20,000 | -20.0% | 0.19% | -39.0% |
| Q1 2015 | $7,051,000 | +66.8% | 25,000 | -7.7% | 0.31% | +114.4% |
| Q4 2014 | $4,228,000 | -34.6% | 27,100 | -0.7% | 0.15% | -7.6% |
| Q3 2014 | $6,462,000 | +5.0% | 27,300 | +5.0% | 0.16% | +17.9% |
| Q2 2014 | $6,152,000 | -36.1% | 26,000 | -11.0% | 0.13% | -30.9% |
| Q1 2014 | $9,630,000 | +125.6% | 29,200 | -53.3% | 0.19% | +110.9% |
| Q4 2013 | $4,268,000 | -22.7% | 62,500 | -21.9% | 0.09% | +55.9% |
| Q3 2013 | $5,522,000 | +207.8% | 80,000 | +100.0% | 0.06% | +13.5% |
| Q2 2013 | $1,794,000 | – | 40,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Carmignac Gestion | 2,028,192 | $229,389,000 | 1.76% |
| Orbimed Advisors | 1,037,000 | $117,285,000 | 1.33% |
| BB BIOTECH AG | 255,719 | $28,922,000 | 0.95% |
| ALTRINSIC GLOBAL ADVISORS LLC | 193,369 | $21,870,000 | 0.74% |
| FALCON POINT CAPITAL, LLC | 44,573 | $5,041,000 | 0.67% |
| Rhenman & Partners Asset Management AB | 30,000 | $3,393,000 | 0.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 11,155 | $1,262,000 | 0.48% |
| NATIONAL PLANNING CORP | 52,400 | $5,888,000 | 0.44% |
| HIGHFIELDS CAPITAL MANAGEMENT LP | 364,232 | $41,195,000 | 0.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 15,000 | $1,697,000 | 0.33% |